Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2024
Cost-effectiveness of pretomanid-based regimen for highly drugresistant TB in a low-burden settingG Fekadu, Y Wang, J H S You
Journal of Clinical Pharmacy and Therapeutics|April 26, 2006
The all-powerful and 'happy' drug: the use of steroids among primary care doctors in Hong KongW C W Wong, J H S You
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 2016
Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysisY-K Pang, M Ip, J H S You
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2007
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysisW L Law, H Y Hui, W M Young, et al.
Clinical Pharmacology and Therapeutics|July 3, 2009
Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapyJ H S You, K K N Tsui, R S M Wong, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?J H S You, F W H Chan, R S M Wong, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 11, 2008
Clinical and economic analyses of antimicrobial therapy in fever wards of a Hong Kong teaching hospitalC-F Mak, D K M Choi, R S M Wong, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2006
Factors associated with healthcare utilization costs for statin therapy--a pilot study in Hong KongC W R Cheng, J C N Chan, B Tomlinson, et al.
Journal of Epidemiology and Community Health|July 18, 2009
Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilitiesJ H S You, W C W Wong, M Ip, et al.
Pageof 2